Breast cancer in young women: Adjuvant therapy and fertility;Cancer du sein chez la jeune femme: Traitements adjuvants et désir de grossesse

Revue Medicale Suisse

Volumn 3, Issue 112, 2007, Pages 1298-1304

  Zaman, Khalil ^a   Jeanneret Sozzi, Wendy ^a   Delaloye, Jean François ^a   De Ziegler, Dominique ^a   Ambrosetti, Alexandra ^b   Perey, Lucien ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HUG   (Switzerland)

^c Hopital de Morges   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GONADORELIN AGONIST; LETROZOLE; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ANXIETY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CRYOPRESERVATION; DEPRESSION; EMOTIONAL STRESS; FEMALE FERTILITY; HORMONAL THERAPY; HUMAN; MULTIPLE CYCLE TREATMENT; PROGNOSIS; QUALITY OF LIFE; REVIEW; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; INFERTILITY, FEMALE;

EID: 34250728156     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. * Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : An overview of the randomised trials. Lancet 2005;365:1687-717.
2. * Duffy CM,Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005; 23:766-73.
3. ** Aebi S. Special issues related to the adjuvant therapy in very young women. Breast 2005;14:594-9.
4. Colleoni M, Rotmensz N, Peruzzotti G, et al. Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 2006;17:1497-503.
5. * Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004;101:1264-74.
6. Kroman N, Holtveg H, Wohlfahrt J, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004;100:688-93.
7. ** Smith IE, Dowsett M, Yap YS, et al. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea : Caution and suggested guidelines. J Clin Oncol 2006;24:2444-7.
8. * Barthelmes L, Davidson LA, Gaffney C, Gateley CA. Pregnancy and breast cancer. BMJ 2005;330:1375-8.
9. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17:2365-70.
10. ** Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005;353:64-73.
11. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91: 3885-90.
12. Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006;24:4888-94.
13. ** Lee SJ, Schover LR, Partridge AH, et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24:2917-31.
14. * Goldhirsch A, Gelber RD, Yothers G, et al. Adjuvant therapy for very young women with breast cancer : Need for tailored treatments. J Natl Cancer Inst Monogr 2001:44-51.